Pacylex Pharmaceuticals Announces First Patient Dosed in a Phase 2a Study of PCLX-001 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

KASTx Life Sciences Fund I Closes First Funding Round

Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease

With AgriTech investments on the rise, the future of agriculture looks bright with the help of AI.

Is Canada ready? Routine use of genome based testing in Canada’s Major Regions. A State of Readiness Progress Report

GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation

Canada needs to invest now to address antimicrobial resistance

CLICK&PUSH ADDS CAMERON LIBRARY TO “THE ATLAS”